Sandbox:AA: Difference between revisions

Jump to navigation Jump to search
Aysha Aslam (talk | contribs)
No edit summary
Aysha Aslam (talk | contribs)
No edit summary
Line 1: Line 1:
Aysha's sandbox
Aysha's sandbox
===Common complications===


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+  
|+  
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Anatomy}}
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Pathogen}}
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Early symptoms}}
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Complications}}
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Late symptoms}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Cervical'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''Group A Streptococcus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
Line 13: Line 13:
*C
*C
*D
*D
|-
| style="padding: 5px 5px; background: #DCDCDC;" |'''Adenovirus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
Line 19: Line 21:
*D
*D
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |'''Thoracic'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''Diphtheria'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
Line 25: Line 27:
*C
*C
*D
*D
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Cocksackie A virus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*E
*A
*F
*B
*C
*D
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Lumbar'''
| style="padding: 5px 5px; background: #DCDCDC;" |'''Ebstein barr virus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
Line 35: Line 41:
*C
*C
*D
*D
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Gonococcus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*
*B
*C
*D
|-
|}
===Uncommon complications===
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Pathogen}}
! style="background: #4479BA; width: 350px;" | {{fontcolor|#FFF|Complications}}
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Diphtheria'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
Line 41: Line 64:
*D
*D
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Sacral'''
| style="padding: 5px 5px; background: #DCDCDC;" |'''Gonococcus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
Line 47: Line 70:
*C
*C
*D
*D
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
| style="padding: 5px 5px; background: #DCDCDC;" | ''''''
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*A
*B
*C
*D
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Cocksackie A virus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*B
*C
*D
|-
| style="padding: 5px 5px; background: #DCDCDC;" |'''Ebstein barr virus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*A
*B
*C
*D
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Gonococcus'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*
*B
*B
*C
*C

Revision as of 16:20, 17 October 2016

Aysha's sandbox

Common complications

Pathogen Complications
Group A Streptococcus
  • A
  • B
  • C
  • D
Adenovirus
  • A
  • B
  • C
  • D
Diphtheria
  • A
  • B
  • C
  • D
Cocksackie A virus
  • A
  • B
  • C
  • D
Ebstein barr virus
  • A
  • B
  • C
  • D
Gonococcus
  • B
  • C
  • D

Uncommon complications

Pathogen Complications
Diphtheria
  • A
  • B
  • C
  • D
Gonococcus
  • A
  • B
  • C
  • D
'
  • A
  • B
  • C
  • D
Cocksackie A virus
  • A
  • B
  • C
  • D
Ebstein barr virus
  • A
  • B
  • C
  • D
Gonococcus
  • B
  • C
  • D

MRI syphilis 17628376


Among women the median prevalence of genital warts was 1.1% (range 0.8 to 2.3) across all jurisdictions, compared to 4.0% (range 2.9 to 4.7) for MSM and 4.9% (range 3.3 to 5.5) for MSW.